Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis
- PMID: 39441357
- DOI: 10.1007/s00134-024-07681-4
Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no conflict of interest.
Similar articles
-
MODIFIED TREATMENT OF HEPATORENAL SYNDROME TYPE I DEPENDING ON THE STAGE OF ACUTE KIDNEY INJURY.Georgian Med News. 2021 May;(314):125-128. Georgian Med News. 2021. PMID: 34248041 Clinical Trial.
-
Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function.Adv Ther. 2023 Dec;40(12):5432-5446. doi: 10.1007/s12325-023-02674-z. Epub 2023 Oct 9. Adv Ther. 2023. PMID: 37812332 Free PMC article.
-
Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.Trials. 2023 Apr 5;24(1):258. doi: 10.1186/s13063-023-07261-9. Trials. 2023. PMID: 37020315 Free PMC article. Clinical Trial.
-
Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.Can J Gastroenterol Hepatol. 2020 Jun 22;2020:5106958. doi: 10.1155/2020/5106958. eCollection 2020. Can J Gastroenterol Hepatol. 2020. PMID: 32676484 Free PMC article.
-
AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.Clin Gastroenterol Hepatol. 2022 Dec;20(12):2707-2716. doi: 10.1016/j.cgh.2022.08.033. Epub 2022 Sep 6. Clin Gastroenterol Hepatol. 2022. PMID: 36075500 Review.
Cited by
-
Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imaging.JHEP Rep. 2025 May 10;7(8):101452. doi: 10.1016/j.jhepr.2025.101452. eCollection 2025 Aug. JHEP Rep. 2025. PMID: 40677691 Free PMC article.
References
-
- Nadim MK, Forni LG, Ostermann M, The ADQI 29/ICA Expert Panel (2024) Terlipressin use in HRS-AKI and respiratory failure. Intensive Care Med. https://doi.org/10.1007/s00134-024-07585-3 - DOI - PubMed - PMC
-
- Arrestier R, Billiet PA, Frapard T, Dessap AM (2024) Terlipressin use in HRS-AKI and respiratory failure. Intensive Care Med. https://doi.org/10.1007/s00134-024-07556-8 - DOI - PubMed
-
- Ma AT, Juanola A, Solé C, Ginès P (2024) Shortening the albumin challenge from 48 to 24 hours may lead to overdiagnosis of hepatorenal syndrome-acute kidney injury and overtreatment with terlipressin. J Hepatol. https://doi.org/10.1016/j.jhep.2024.07.015 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources